Nama Insights

iShares Biotechnology ETF (IBB)

Health · iShares · NASDAQ

HealthETF
iShares Biotechnology ETF (IBB) is an exchange-traded fund in the Health category. It has $10.47B in assets, an expense ratio of 0.44% and a 0.20% dividend yield. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Assets under management$10.47B
Expense ratio0.44%
CategoryHealth
Dividend yield0.20%
NAV$204.77
Fund familyiShares
ExchangeNASDAQ

Top holdings

The largest positions iShares Biotechnology ETF reports, by weight.

HoldingNameWeight
AMGN Amgen Inc 8.45%
VRTX Vertex Pharmaceuticals Inc 8.06%
GILD Gilead Sciences Inc 7.21%
REGN Regeneron Pharmaceuticals Inc 5.72%
ARGX argenx SE ADR 3.80%
MRNA Moderna Inc 3.62%
NTRA Natera Inc 3.12%
RVMD Revolution Medicines Inc Ordinary Shares 2.78%
ILMN Illumina Inc 2.29%
ALNY Alnylam Pharmaceuticals Inc 2.27%

Other Health ETFs

Explore live IBB data on Nama Insights →